etoposide has been researched along with Hyperpigmentation in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ellis, D; Necessary, CA; Roffwarg, D | 1 |
Hao, L; Mahmoud, F | 1 |
Blackwell, S; Buchanan, M; Clark, RE; Crawford, J; Grichnik, JM; Hitchcock, MG; Jimenez, F; Kurtzberg, J | 1 |
Craft, AW; Pearson, AD; Yule, SM | 1 |
1 trial(s) available for etoposide and Hyperpigmentation
Article | Year |
---|---|
Human recombinant stem-cell factor induces melanocytic hyperplasia in susceptible patients.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Adhesion Molecules; Dendrites; Disease Susceptibility; Etoposide; Follow-Up Studies; Hematopoietic Cell Growth Factors; Humans; Hyperpigmentation; Hyperplasia; Injections, Subcutaneous; Lung Neoplasms; Melanins; Melanocytes; Recombinant Proteins; Stem Cell Factor | 1995 |
3 other study(ies) available for etoposide and Hyperpigmentation
Article | Year |
---|---|
Reticulated hyperpigmentation following chemotherapy for radiation-induced osteosarcoma.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Eruptions; Etoposide; Humans; Hyperpigmentation; Ifosfamide; Male; Methotrexate; Middle Aged; Neoplasms, Radiation-Induced; Orbital Neoplasms; Osteosarcoma; Triamcinolone | 2014 |
Image Diagnosis: A Striking Bleomycin-Induced Skin Toxicity: Flagellate Hyperpigmentation.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Bleomycin; Cisplatin; Drug Therapy, Combination; Etoposide; Humans; Hyperpigmentation; Lymphadenopathy; Male; Orchiectomy; Teratoma; Testicular Neoplasms; Tomography, X-Ray Computed | 2017 |
Ifosfamide-induced hyperpigmentation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Etoposide; Female; Humans; Hyperpigmentation; Ifosfamide; Infant; Male; Sarcoma; Time Factors | 1994 |